Inspections and Precautionary Measures in Panama: Powers and Remedies
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The on-site powers of the Panamanian health authority over devices are granted directly by statute and do not require a prior finding of infringement. Article 30 of Ley 90 authorises DNDM to verify the infrastructure, equipment, hygiene and environmental conditions of a premises and to issue an acta stating those conditions and whether the premises are suitable for the relevant activity. Article 31 authorises inspections on the authority’s own initiative or on the basis of a complaint, a vigilance report, an event or failure, and allows that power to be delegated to the Regional Health Authorities. Article 32 caps the investigation at 90 working days from receipt of the complete file. Article 41 authorises temporary or precautionary measures, including the publication of information, temporary closure of premises and seizure or sealing of products, with police chiefs obliged to provide assistance. Article 43 authorises retention of non-compliant products and confiscation by reasoned resolution. At decree level, Article 63 of DE 490 allows DNDM to order seizure or suspension and to prohibit or restrict use until an investigation ends, and requires rules on quarantine.
2. Legal basis
The inspection framework separates three questions that are often conflated: what the inspector may examine, how long the investigation may run, and what may be done to the product while it runs. The table sets out those powers together with the sanction catalogue, the rules on how penalties are measured, the appeal route and the procedural notification rule that governs the whole sequence.
| Ley No. 90 (2017-12-26, Gaceta Oficial Digital No. 28433-B) | Article 30 | DNDM may verify infrastructure, equipment, hygiene and environmental conditions for manufacture, preparation, import, export, distribution, sale and storage, and issue an acta on the conditions and suitability of the premises |
| Same | Article 31 | Inspections may be ordered on the authority’s own initiative or on complaint, suspicion, vigilance report, event or incident, device failure or any situation affecting public health; the power may be delegated to the Regional Health Authorities |
| Same | Article 32 | The investigation procedure follows the risk level of the event, incident or failure; the investigation period does not exceed 90 working days from receipt of the complete file, as defined in the regulations |
| Same | Article 33 | Manufacturers, suppliers and all medical, scientific and technical personnel must report suspicions concerning events, incidents, failures and alerts |
| Same | Article 41 | Without prejudice to its sanctioning powers, DNDM may adopt temporary or precautionary measures to protect life, health and physical integrity, including publication of information, temporary closure of premises and seizure or sealing of products; police chiefs must cooperate |
| Same | Article 43 | DNDM may order retention of devices and related products that do not meet the law, and confiscation by reasoned resolution |
| Same | Article 39 | Six sanctions: written warning; suspension or cancellation of the CVT; suspension or cancellation of the sanitary registration; suspension or cancellation of the operating licence; suspension of business or closure of premises; fines |
| Same | Article 42 | Sanctions may be challenged by reconsideration and appeal, both with devolutive effect; the administrative route is exhausted once the appeal is decided |
| Same | Article 40 | In setting the penalty DNDM must consider the extent of personal harm caused, the illicit profit obtained and recidivism |
| Same | Article 36 item 2 | Obstructing an investigation or inspection is a serious offence |
| Decreto Ejecutivo No. 490 (2019-10-04, Gaceta 28875-A) | Article 19 | DNDM may carry out inspections without prior notice; sale is prohibited in full while the operating licence is invalid |
| Same | Article 63 | Where a serious adverse event occurs despite correct use and maintenance, DNDM may order seizure or suspension and prohibit or restrict use until the investigation ends; quarantine rules to be issued |
| Same | Article 30, second paragraph | Where a product falls within two classes at the same time, the higher class applies |
| Same | Article 71 | Notification of related procedures follows Ley 38 de 2000 |
3. Expert insights
Insight 1: the Article 41 measures are an authorisation separate from the sanctioning power. The opening words are without prejudice to the sanctioning powers established. The legal effect is substantial: when DNDM publishes information, closes premises temporarily or seizes or seals products, it does not need to complete a finding of infringement or exhaust a penalty procedure first. The company response therefore cannot be to wait for a characterisation and then argue; it can only be to remain inspectable at all times.
Insight 2: inspection authority reaches the regions, so premises outside the capital are covered. The closing sentence of Article 31 allows the power to be delegated to the Regional Health Authorities. Read with Article 3 of DE 490 on DNDM intervention in free zones, on-site supervision is not concentrated in Panama City. A company operating a warehouse in the Colón Free Zone cannot estimate inspection probability on the assumption that it is far from the regulator.
Insight 3: the 90 working days run from the complete file, so supplements restart the rhythm. Article 32 measures from receipt of the complete documentation. The length of the investigation is therefore determined almost entirely by whether the material is delivered in one go. This is the one lever a company controls inside the procedure: a single complete submission locks in the 90 working day ceiling, while piecemeal supplements give it up.
Insight 4: the police assistance clause gives the measures immediate coercive force. Police chiefs are obliged to provide cooperation and assistance, and Article 43 allows confiscation by resolution while Article 63 of DE 490 allows use to be prohibited or restricted during the investigation. For a public hospital programme that depends on continuous supply, a single precautionary measure can trigger contractual default, which is a higher risk than the fine itself.
4. Practical recommendations
- Keep an inspection file at every site. At minimum: original operating licence, copies of the CCT and CVT, import invoices with the twelve Article 27 items, label specimens with the twelve Article 40 items, instructions with the seventeen Article 38 items, vigilance records and the officer appointment letter. Because the power is delegable, every warehouse needs its own set.
- Cooperate, and avoid escalation to a serious offence. Article 36.2 makes obstruction a serious offence with fines from B/.5,001.00 under Article 44.2. Staff should be trained not to block, not to delay and to sign the acta on the spot.
- Treat the acta as the starting point of the evidence. Article 30 requires an acta stating the conditions and suitability of the premises; confirm its content with the inspector and note any discrepancy immediately, keeping a copy.
- Run two remedies in parallel when a measure is imposed. Reconsideration and appeal under Article 42, both with devolutive effect, and a check under Article 71 of DE 490 that notification complied with Ley 38 de 2000. Procedural defects are often the fastest route to lifting a measure.
- Do not substitute a remediation promise for readiness. Precautionary measures do not require a finding of infringement, so retrospective correction cannot prevent the measure from taking effect.
5. Verification checklist
- □ Inspection file complete at every operating and storage site, covering licence, CCT or CVT, invoices, labels, instructions and vigilance records
- □ Delegation of inspection power to the Regional Health Authorities recorded, including sites outside the capital
- □ Staff trained not to obstruct, with the Article 36.2 serious offence and B/.5,001.00 threshold explained
- □ Acta signature and copy retention procedure defined under Article 30
- □ Article 32 start date recorded as the day the complete file is received, with a single submission planned
- □ Three Article 41 measures and the police assistance duty recorded
- □ Article 43 retention and reasoned confiscation, and Article 63 suspension and quarantine powers recorded
- □ Remedies confirmed: Article 42 reconsideration and appeal with devolutive effect, plus Article 71 compliance with Ley 38 de 2000
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Panamanian market. Our team manages Ministry of Health (MINSA) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us